Navigation Links
Biothera's Imprime PGG Enhanced Effectiveness of Avastin in Cancer,Study

EAGAN, Minn.--(BUSINESS WIRE)--Jun 4, 2007 - Imprime PGG(TM), an investigational new drug from Biothera that enhances the innate immune system response, increases the effectiveness of Avastin(R) (bevacizumab) to kill cancer cells, according to new preclinical research presented yesterday at the 2007 American Society of Clinical Oncology Annual Meeting in Chicago.

Researchers at the Brown Cancer Center, University of Louisville, Kentucky, studied the synergistic effects of Imprime PGG in combination with Avastin in a xenograft mouse model where human ovarian cancer cells were implanted into the mice. In the treatment group receiving both Imprime PGG and Avastin, 86% of the mice survived 100 days compared with only 43% in the group receiving Avastin alone.

"The combination of Imprime PGG and Avastin should be considered as potential treatment approach in patients with VEGF-expressing tumors and needs to be further investigated in clinical trials," said Carolina Salvador, M.D., a clinical instructor at the Brown Cancer Center.

"The results are consistent with previous research demonstrating improved outcomes for both tumor size and long-term survival when Imprime PGG is combined with complement-activating monoclonal antibodies," said Daniel K. Conners, president of Biothera's Pharmaceutical Group. "Our technology has the potential to dramatically enhance both existing and developmental drug treatments for most major types of cancer."

The ASCO poster presentation is entitled, "Cytotoxicity of Bevacizumab is Enhanced by Beta-glucan in Tumors Expressing Membrane-Bound VEGF." Dr. Salvador conducted the research in collaboration with Jun Yan, MD, Ph.D., the lead researcher at the Tumor Immunobiology Program at the Brown Cancer Center.

About Imprime PGG(TM)

Imprime PGG is a biological response modifier that enhances specific innate immune cell responses. Biothera has completed two Phas
'"/>




Page: 1 2

Related medicine technology :

1. Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting
2. Favrille Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma
3. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
4. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
5. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
6. St. Jude Study Shows Effectiveness of Peramivir in Prevention of Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection
7. Study Supports Cost-Effectiveness of Medtronics Spasticity Treatment for Children with Cerebral Palsy
8. FDA MedWatch: Avastin (bevacizumab) and Formation of Tracheoesophageal Fistula in a Recent Clinical Study in Patients with Limited-stage Small Cell Lung Cancer
9. Data Presented at AACR Meeting Shows Peregrines Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
10. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
Post Your Comments:
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: ... development and commercialization of products for central nervous ... two posters at the Society for Research on ... The first poster entitled Pleiomorphic ... provides insight into the challenges faced by ...
(Date:5/22/2012)... -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it ... and Drug Administration for its abbreviated new drug ... the generic equivalent of Gynazole·1®. Perrigo was the first ... a paragraph IV certification and is entitled to ... KV Pharmaceutical Company on a collaboration to launch ...
(Date:5/22/2012)... AUSTIN, Texas, May 22, 2012  Prodigy Generics, ... has launched injectable irinotecan. Irinotecan is the generic ... Prodigy partnered with eVenus Pharmaceutical Laboratories ... is the first of several ANDAs being developed ... and exceptional value to the U.S. injectable market, ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3Infant Organ Donors Could Help Meet Transplant Needs 3A Study 78200 1Infant Organ Donors Could Help Meet Transplant Needs 3A Study 78200 2Scripps Research chemist devises new method to quantify protein changes 17165 1Scripps Research chemist devises new method to quantify protein changes 17165 2Scripps Research chemist devises new method to quantify protein changes 17165 3Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC 1002 13706 1Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC 1002 13706 2
(Date:5/23/2012)... research suggests that young asthma patients who use drugs ... -- could be more likely than others to suffer ... increased risk was not seen for some types of ... the recent interest in use of anticholinergics in asthma," ... at Chicago, said in a news release from the ...
(Date:5/23/2012)... treatment with inhaled corticosteroids in patients with respiratory ... associated with a lower incidence and severity of ... researchers in Spain. , A parapneumonic effusion is ... accumulates between the two pleural layers, the fluid-filled ... a result of a pneumonia, lung abscess, or ...
(Date:5/22/2012)... Ill. Magnetic resonance imaging (MRI) provides an ... chemotherapy significantly earlier than possible through clinical examination, ... the journal Radiology . , Women ... surgery. Research has shown that women who receive ... likely to achieve breast conservation than those receiving ...
(Date:5/22/2012)... HealthDay Reporter , , TUESDAY, May 22 (HealthDay News) -- ... common cause of snoring and daytime sleepiness, might also ... the condition -- the risk of developing high blood ... new cases of high blood pressure in two groups ... therapy, or CPAP, for either about four or 11 ...
(Date:5/22/2012)... 22, 2012) -- Researchers at Barrow Neurological Institute ... unveiled how and why the public perceives some ... real-world implications in military tactics, marketing and sports. ... Visual Neuroscience, and Stephen Macknik, PhD, of Barrow,s ... their research into magic and illusions. Their most ...
Breaking Medicine News(10 mins):Health News:Asthma Meds May Be Linked to Irregular Heartbeat 2Health News:Long-term ICS use reduces pleural effusion in patients with CAP 2Health News:Breast MRI helps predict chemotherapy's effectiveness 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 3Health News:Sleep Apnea 'Mask' Might Also Help the Heart 4Health News:Barrow researchers use magic for discoveries 2
... planning to recruit 50,000 people as a part of a large ... relationship // between lifestyle and genetics as regards the health of ... two decades and is one of the largest healthcare projects in ... large pool of information so that it would be easy to ...
... Life of Life Healing Spa is increasingly getting more customers ... the very first session. // Owner Karen Chu claims that ... degree of success since the spa first began offering the ... given here has not yet resulted in any injuries. Most ...
... after eating a single sweet as she suffered from nut ... cream cake but had // failed to identify the chocolate-covered ... and lost consciousness in an hour’s time. She was immediately ... causing irreversible brain damage. , ,Five days later, ...
... and cancer drugs which it hopes will increase its sales ... starting // to market two of its new diabetes drug ... treating type 2 diabetes. ,The drug Avandaryl is ... the drug Avandamet is produced by the combination of Avandina ...
... countrymen safe drinking water within a matter of four ... // to make this possible. Most people living in ... water. ,Inaugurating a conference of ministers ... sanitation in states and union territories, the prime minister ...
... per a study in Tanzania by Duke University Medical Centre, it ... cost effective than charging a small fee for them. // ... free test rather than a charged test. ,The statistics ... a two-week pilot program in 2003. ,The numbers which ...
Other Medicine News:Health News:Safe Drinking Water To Be Made Available 2Health News:Free HIV Tests far more cost effective than small fee 2
... CryoCath has developed a minimally ... reentrant tachycardia. It delivers a very ... site confirmation, pinpoint site precision, minimal ... thrombus and stenosis., ,Freezor Xtra allows ...
... CryoCath has developed a minimally invasive ... tachycardia. It delivers a very high ... confirmation, pinpoint site precision, minimal tissue ... and stenosis., ,Freezor is a flexible, ...
The Medtronic CardioRhythm Marinr Catheter is intended for use in diagnostic electrophysiologic procedures. These catheters are designed for recording intracardiac electrograms and temporary pacing a...
Ten-Ten duodecapolar diagnostic mapping catheters are available in four curve sizes....
Medicine Products: